The effect of MELatOnin on Depression, anxietY, cognitive function and sleep disturbances in patients with breast cancer. The MELODY trial: protocol for a randomised, placebo-controlled, double-blinded trial

INTRODUCTION: Breast cancer represents about one-third of all cancer diagnoses and accounts for about 15% of cancer deaths in women. Many of these patients experience depression, anxiety, sleep disturbances and cognitive dysfunction. This may adversely affect quality of life and also contribute to m...

Descripción completa

Detalles Bibliográficos
Autores principales: Hansen, Melissa Voigt, Madsen, Michael Tvilling, Hageman, Ida, Rasmussen, Lars Simon, Bokmand, Susanne, Rosenberg, Jacob, Gögenur, Ismail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Group 2012
Materias:
Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278491/
https://www.ncbi.nlm.nih.gov/pubmed/22240653
http://dx.doi.org/10.1136/bmjopen-2011-000647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278491/
https://www.ncbi.nlm.nih.gov/pubmed/22240653
http://dx.doi.org/10.1136/bmjopen-2011-000647

Ejemplares similares